drugset / Trial / NCT03775174
Summary
Individual patient expanded access requests may be considered for patients who have no other treatment options
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | vestronidase alfa | Protein / enzyme biologic | — | — |